Sunshine Biopharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
31.20
143.40
50.80
57.50
107.50
115.20
Total Accounts Receivable
-
-
3.10
-
-
95
Other Current Assets
-
-
-
1.00
9.70
1.30
Total Current Assets
31.20
143.40
53.90
58.50
117.20
211.50
Net Property, Plant & Equipment
-
-
4.30
5.90
60.00
269.40
Intangible Assets
-
-
615.00
-
-
665.70
Other Assets
-
-
-
-
80.30
-
Total Assets
31.20
143.40
673.30
64.40
257.50
1,146.60
ST Debt & Current Portion LT Debt
12.50
480.10
1,140.60
237.00
722.60
Accounts Payable
23.80
34.80
127.10
-
-
Other Current Liabilities
2.60
16.10
2.70
37.10
28.50
Total Current Liabilities
39.00
531.00
1,270.30
274.10
751.10
Long-Term Debt
-
-
-
-
79.70
Total Liabilities
39.00
531.00
1,270.30
274.10
830.80
Common Equity (Total)
7.70
387.60
647.00
259.70
623.40
Total Shareholders' Equity
7.70
387.60
597.00
209.70
573.40
Total Equity
7.70
387.60
597.00
209.70
573.40
Liabilities & Shareholders' Equity
31.20
143.40
673.30
64.40
257.50
Preferred Stock (Carrying Value)
-
-
50.00
50.00
50.00
About Sunshine Biopharma
View Profile
